Evidence map›Paper›PMID 42730839›Full record

ArticleVirchows Archiv : an international journal of pathology2026

Invasive carcinoma ex intraductal carcinoma of the salivary gland showing extensive infiltrative growth despite deceptively low-grade cribriform morphology.

Meejeong Kim, Jun-Ook Park, Dong-Il Sun, Youn Soo Lee

Abstract read
PubMed Publisher
In one paragraph

Article in Virchows Archiv : an international journal of pathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Meejeong KimDepartment of Hospital Pathology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Jun-Ook ParkDepartment of Otolaryngology-Head and Neck Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Dong-Il SunDepartment of Otolaryngology-Head and Neck Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Youn Soo LeeDepartment of Hospital Pathology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea. lys9908@catholic.ac.kr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Intraductal carcinoma (IDC) of the salivary gland is an uncommon neoplasm frequently associated with RET rearrangements, particularly in the intercalated duct subtype. Although invasive carcinoma ex IDC has increasingly been recognized, most reported cases have demonstrated overtly invasive or high-grade morphology distinct from the associated intraductal component. Herein, we report a case of NCOA4::RET fusion-positive IDC of the parotid gland showing extensive infiltrative growth into adjacent soft tissue despite deceptively low-grade cribriform histomorphology. Tumor cells showed diffuse SOX10 and S100 expression, supporting intercalated duct differentiation, while cribriform nests demonstrated heterogeneous myoepithelial cell preservation, ranging from an intact peripheral layer to its complete absence. Targeted next-generation sequencing identified an in-frame NCOA4::RET fusion. This case expands the morphologic spectrum of invasive carcinoma ex IDC and highlights that unequivocal infiltrative growth may occur despite retention of a deceptively low-grade feature.

Indexed as

Cribriform morphologyIntraductal carcinomaInvasive carcinoma ex intraductal carcinomaNCOA4:RET fusionSalivary gland

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.